ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS

A securities class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false and misleading statements regarding consumer data sharing with third-party advertising platforms, charging for prescriptions before medical consultations, and failing to disclose regulatory scrutiny and potential penalties. The lead plaintiff deadline is November 2, 2026.

10/02/2026, 2:41 PM • GlobeNewswire

Kaplan Fox Notifies Investors of Hims & Hers Health, Inc. (NYSE: HIMS) of a Securities Fraud Class Action Deadline on November 2, 2026

Kaplan Fox has filed a securities class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased securities between August 4, 2025 and July 29, 2026. The FTC sued the company for allegedly failing to disclose immediate prescription charges, making subscription cancellations difficult, and sharing consumers' health information with third-party advertising platforms like Meta and Snap. The stock fell 14.73% to $25.00 per share following the FTC action. The lead plaintiff deadline is November 2, 2026.

10/02/2026, 11:00 AM • GlobeNewswire

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP announces a securities fraud class action lawsuit against Hims & Hers Health, Inc. for making false and misleading statements regarding customer health data sharing with third-party advertising platforms and treatment practices that could trigger regulatory scrutiny. The class period spans August 4, 2025 to July 29, 2026, with a November 2, 2026 deadline for investors to participate.

10/02/2026, 9:54 AM • GlobeNewswire

1 MONTH INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement.

10/02/2026, 6:50 AM • GlobeNewswire

DEADLINE ALERT for HYLN, HIMS, UNCY, BIDU: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has filed securities fraud class action lawsuits against four publicly-traded companies: Hyliion Holdings Corp., Hims & Hers Health Inc., Unicycive Therapeutics Inc., and Baidu Inc. The lawsuits allege that defendants made materially false and misleading statements and failed to disclose material adverse facts about their respective businesses. Investors have until specified deadlines in late October and November 2026 to file lead plaintiff motions.

10/01/2026, 4:00 PM • GlobeNewswire

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Hims & Hers Health faces a securities class action lawsuit after the FTC alleged the telehealth provider shared consumers' sensitive health information with third-party advertising platforms and engaged in deceptive billing practices. The stock fell 14.73% to $25.00 on July 29, 2026, following the FTC announcement. Investors with losses exceeding $100,000 have until November 2, 2026 to file lead plaintiff applications.

09/30/2026, 11:49 PM • GlobeNewswire

Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit—HBSS

Hims & Hers Health (HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company shared consumers' health data with third-party advertisers like Meta and Snap, charged for prescriptions before medical consultations, and violated ROSCA regulations. The stock dropped 14.7% on July 29, 2026, erasing over $970 million in market value. Investors with substantial losses are encouraged to participate in the class action.

09/30/2026, 10:59 AM • GlobeNewswire

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Hims & Hers Health faces a securities fraud class action lawsuit after the FTC alleged the telehealth provider shared consumers' sensitive health information with third-party advertisers while claiming to maintain privacy, and deceived users about billing and cancellation practices. The stock declined 14.73% on July 29, 2026, following the FTC announcement. Investors who purchased securities between August 4, 2025 and July 29, 2026 have until November 2, 2026 to file lead plaintiff applications.

09/29/2026, 10:01 PM • GlobeNewswire

Deadline Alert: Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

The FTC filed a lawsuit against Hims & Hers Health, Inc. on July 29, 2026, alleging the telehealth provider shared consumers' sensitive health information with third-party advertising platforms while claiming to maintain privacy, and deceived users about billing and cancellation practices. The stock declined 14.73% on the news. A class action lawsuit has been filed, with a November 2, 2026 deadline for investors to file lead plaintiff motions.

09/29/2026, 2:40 PM • GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS

Rosen Law Firm is soliciting investors who purchased Hims & Hers Health securities between August 4, 2025 and July 29, 2026 to join a class action lawsuit. The lawsuit alleges that Hims made materially false statements regarding data privacy practices, prescription charging procedures, and regulatory compliance, leading to investor damages when the true details became public.

09/25/2026, 7:24 PM • GlobeNewswire

HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm

A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false statements about its privacy practices. The FTC accused HIMS of sharing customers' medical information with third-party advertisers including Meta and Snap, and charging consumers for prescriptions without proper consultation. The stock declined 14.73% on the news, dropping $4.32 per share to $25.00 on July 29, 2026.

09/25/2026, 4:51 PM • GlobeNewswire

HIMS Stockholders Have Rights – If You Lost Money Investing in Hims & Hers Health, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP announced a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing customers' protected health information with third-party advertising platforms and engaging in deceptive billing practices. The FTC filed a separate lawsuit on July 29, 2026, which triggered a 14.73% stock decline. Investors who purchased HIMS securities between August 4, 2025 and July 29, 2026 may be eligible to participate in the class action.

09/25/2026, 2:10 PM • GlobeNewswire

Shareholders who lost money in shares of acquired Doximity, Inc. (NYSE: DOCS) should contact Wolf Haldenstein Immediately

Wolf Haldenstein has filed class action lawsuits against Doximity, Papa John's International, and Hims & Hers Health on behalf of shareholders who suffered losses. The lawsuits allege that these companies made false or misleading statements regarding their financial performance and business prospects. Doximity's stock declined significantly following multiple guidance misses and revenue warnings between November 2025 and May 2026.

09/23/2026, 5:54 PM • GlobeNewswire

AEVEX Corp. Notice of October 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kahn Swick & Foti, LLC announces class action securities lawsuits against AEVEX Corp., Avis Budget Group, and Hims & Hers Health. AEVEX investors who purchased stock between April 17-June 4, 2026 can join the lawsuit alleging the company concealed a pre-arranged plan to override a 180-day lock-up agreement, allowing major shareholder Madison to sell shares and underwriters to collect additional fees. The application deadline for AEVEX is October 20, 2026.

09/22/2026, 7:00 PM • GlobeNewswire

Deadline Alert: DICK’s Sporting Goods, Inc. (DKS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Class action lawsuits have been filed against DICK's Sporting Goods, Papa John's International, and Hims & Hers Health for alleged securities fraud. DICK's stock fell 30.68% after reporting disappointing Q2 2026 results and reduced guidance, citing increased promotional pressures in the athletic footwear market and underperformance of its Foot Locker acquisition. Investors who suffered losses are urged to file lead plaintiff motions by the respective deadlines in early November 2026.

09/22/2026, 1:50 PM • GlobeNewswire